undamentalytics Newsletter

Winkelried Jon: insider trades

Chief executive, 10% owner, Other at 8 companies we cover. No open-market purchases and 13 sales not made under a pre-set plan, reported from July 1, 2022 to January 26, 2026.

What happened after Winkelried Jon’s sales?

After their sales, the shares moved −16.6% against the index over 12 months on average (a negative figure means selling was the right call); 60% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Winkelried Jon: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 6 −11.1% −10.2% 83% 4 −3.29 0.046 Some evidence: seller right
Sales, 12 months after the report 5 −16.6% −8.5% 60% 3 — — Not enough years
Sales, 12 months after the trade 5 −20.6% −11.9% 80% 3 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Super League Enterprise, Inc. SLE —05June 8, 2023July 18, 2023
Trevi Therapeutics, Inc. TRVI —02July 1, 2022July 6, 2022
Progyny, Inc. PGNY —01November 9, 2022November 9, 2022
Nextpower Inc. NXT —01February 7, 2024February 7, 2024
TPG Inc. TPG Chief Executive Officer01February 29, 2024February 29, 2024
Lifestance Health Group, Inc. LFST —01May 29, 2024May 29, 2024
Life Time Group Holdings, Inc. LTH —01June 10, 2025June 10, 2025
Sionna Therapeutics, Inc. SION —01January 26, 2026January 26, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
January 26, 2026January 22, 2026 SION Sale $10,000,000 −11.4%not yetnot yet
June 10, 2025June 6, 2025 LTH Sale $245,159,001 −2.8%0.0%−11.9%
May 29, 2024May 24, 2024 LFST Sale $85,835,070 +5.2%−8.5%−9.2%
February 29, 2024February 29, 2024 TPG Sale $43,757,311 −9.0%+1.7%+1.7%
February 7, 2024February 5, 2024 NXT Sale $622,600,000 −29.1%−44.0%−39.9%
July 18, 2023July 14, 2023 SLE Sale $43,065 not yetnot yetnot yet
June 28, 2023June 26, 2023 SLE Sale $33,800 not yetnot yetnot yet
June 14, 2023June 12, 2023 SLE Sale $24,800 not yetnot yetnot yet
June 12, 2023June 8, 2023 SLE Sale $38,340 not yetnot yetnot yet
June 8, 2023June 6, 2023 SLE Sale $99,292 not yetnot yetnot yet
November 9, 2022November 7, 2022 PGNY Sale $29,062,500 −19.4%−32.4%−43.8%
July 6, 2022July 1, 2022 TRVI Sale $1,445,892 not yetnot yetnot yet
July 1, 2022June 29, 2022 TRVI Sale $1,317,042 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Winkelried Jon traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.